RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tandem Diabetes Care Stock

Tandem Diabetes Care Revenue 2024

Tandem Diabetes Care Revenue

908.62 M USD

Ticker

TNDM

ISIN

US8753722037

WKN

A2H5BX

In 2024, Tandem Diabetes Care's sales reached 908.62 M USD, a 21.52% difference from the 747.72 M USD sales recorded in the previous year.

The Tandem Diabetes Care Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e1.4126,02
2028e1.2828,84
2027e1.1731,35
2026e1.1432,37
2025e1.0236,19
2024e0.9140,47
20230.7549,17
20220.851,55
20210.753,53
20200.552,23
20190.3653,60
20180.1848,83
20170.1140,99
20160.0828,03
20150.0736,49
20140.0530,58
20130.0321,38
20120-52,00
2011--

Tandem Diabetes Care Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Tandem Diabetes Care, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Tandem Diabetes Care from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Tandem Diabetes Care’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Tandem Diabetes Care. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Tandem Diabetes Care’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Tandem Diabetes Care’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Tandem Diabetes Care’s growth potential.

Tandem Diabetes Care Revenue, EBIT and net profit per share

DateTandem Diabetes Care RevenueTandem Diabetes Care EBITTandem Diabetes Care Net Income
2029e1.41 B undefined0 undefined70.11 M undefined
2028e1.28 B undefined-42.43 M undefined-30.05 M undefined
2027e1.17 B undefined-54.67 M undefined-54.75 M undefined
2026e1.14 B undefined-52.13 M undefined-46.85 M undefined
2025e1.02 B undefined-82.02 M undefined-78.84 M undefined
2024e908.62 M undefined-118.2 M undefined-115.27 M undefined
2023747.72 M undefined-154.48 M undefined-222.61 M undefined
2022801.2 M undefined-92.8 M undefined-94.6 M undefined
2021702.8 M undefined22.7 M undefined15.6 M undefined
2020498.8 M undefined-8 M undefined-34.4 M undefined
2019362.3 M undefined-16.7 M undefined-24.8 M undefined
2018183.9 M undefined-44.6 M undefined-122.6 M undefined
2017107.6 M undefined-62.9 M undefined-73 M undefined
201684.2 M undefined-78.1 M undefined-83.4 M undefined
201572.9 M undefined-69 M undefined-72.4 M undefined
201449.7 M undefined-75.7 M undefined-79.5 M undefined
201329 M undefined-49.4 M undefined-63.1 M undefined
20122.5 M undefined-33 M undefined-33 M undefined
20110 undefined-24.2 M undefined-25.5 M undefined

Tandem Diabetes Care stock margins

The Tandem Diabetes Care margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Tandem Diabetes Care. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Tandem Diabetes Care.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Tandem Diabetes Care's sales revenue. A higher gross margin percentage indicates that the Tandem Diabetes Care retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Tandem Diabetes Care's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Tandem Diabetes Care's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Tandem Diabetes Care's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Tandem Diabetes Care. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Tandem Diabetes Care's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Tandem Diabetes Care Margin History

Tandem Diabetes Care Gross marginTandem Diabetes Care Profit marginTandem Diabetes Care EBIT marginTandem Diabetes Care Profit margin
2029e49.17 %0 %4.96 %
2028e49.17 %-3.33 %-2.36 %
2027e49.17 %-4.66 %-4.67 %
2026e49.17 %-4.59 %-4.12 %
2025e49.17 %-8.07 %-7.76 %
2024e49.17 %-13.01 %-12.69 %
202349.17 %-20.66 %-29.77 %
202251.55 %-11.58 %-11.81 %
202153.53 %3.23 %2.22 %
202052.23 %-1.6 %-6.9 %
201953.6 %-4.61 %-6.85 %
201848.83 %-24.25 %-66.67 %
201740.99 %-58.46 %-67.84 %
201628.03 %-92.76 %-99.05 %
201536.49 %-94.65 %-99.31 %
201430.58 %-152.31 %-159.96 %
201321.38 %-170.34 %-217.59 %
2012-52 %-1,320 %-1,320 %
201149.17 %0 %0 %

Tandem Diabetes Care Aktienanalyse

What does Tandem Diabetes Care do?

Tandem Diabetes Care Inc is an American medical technology company specializing in the development and marketing of insulin pumps and accessories. The company was founded in 2006 and is headquartered in San Diego, California. Answer: Tandem Diabetes Care Inc is an American medical technology company specializing in insulin pumps and accessories. It was founded in 2006 and is based in San Diego, California. Tandem Diabetes Care ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Tandem Diabetes Care's Sales Figures

The sales figures of Tandem Diabetes Care originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Tandem Diabetes Care’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Tandem Diabetes Care's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Tandem Diabetes Care’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Tandem Diabetes Care stock

How much revenue did Tandem Diabetes Care generate this year?

Tandem Diabetes Care has achieved a revenue of 908.62 M USD this year.

How much was the turnover of the company Tandem Diabetes Care compared to the previous year?

The revenue of Tandem Diabetes Care has increased by 21.52% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Tandem Diabetes Care?

The revenue of Tandem Diabetes Care is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Tandem Diabetes Care measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Tandem Diabetes Care so important for investors?

The revenue of Tandem Diabetes Care is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Tandem Diabetes Care pay?

Over the past 12 months, Tandem Diabetes Care paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tandem Diabetes Care is expected to pay a dividend of 0 USD.

What is the dividend yield of Tandem Diabetes Care?

The current dividend yield of Tandem Diabetes Care is .

When does Tandem Diabetes Care pay dividends?

Tandem Diabetes Care pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tandem Diabetes Care?

Tandem Diabetes Care paid dividends every year for the past 0 years.

What is the dividend of Tandem Diabetes Care?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tandem Diabetes Care located?

Tandem Diabetes Care is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tandem Diabetes Care kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tandem Diabetes Care from 9/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Tandem Diabetes Care pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Tandem Diabetes Care in the year 2023?

In the year 2023, Tandem Diabetes Care distributed 0 USD as dividends.

In which currency does Tandem Diabetes Care pay out the dividend?

The dividends of Tandem Diabetes Care are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tandem Diabetes Care

Our stock analysis for Tandem Diabetes Care Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tandem Diabetes Care Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.